M&A
Lilly Completes Acquisition of Loxo Oncology
Eli Lilly and Company
PR-M02-19-NI-041Feb 20, 2019
Annoucement
Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction
Eli Lilly and Company
PR-M02-19-NI-003Feb 04, 2019
Oncology
Lilly to Spend $8 Billion on Loxo Oncology
Emilie Branch
Pharma's Almanac
PAO-M01-19-NI-016Jan 29, 2019
Loxo Oncology Reports Positive Results for Second Targeted Cancer Therapy
Guy Tiene
Nice Insight
PAO-M06-18-NI-001Jun 05, 2018